S433 200 mg (Carbamazepine extended-release 200 mg)
Pill imprint S433 200 mg has been identified as Carbamazepine extended-release 200 mg.
Carbamazepine is used in the treatment of bipolar disorder; trigeminal neuralgia; epilepsy; schizoaffective disorder; borderline personality disorder (and more), and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 200 mg is not a controlled substance under the Controlled Substance Act (CSA).
- S433 200 mg
- 200 mg
- Gray / Green
- Prescription only
- Drug Class:
- Dibenzazepine anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Prasco Laboratories
- National Drug Code (NDC):
- Inactive Ingredients:
- citric acid monohydrate
sodium lauryl sulfate
FD&C Red No. 3
FD&C Yellow No. 6
ferric oxide yellow
FD&C Blue No. 2
More about carbamazepine
- Carbamazepine chewable tablets
- Carbamazepine suspension
- Carbamazepine sustained-release capsules
- Carbamazepine sustained-release tablets
- Carbamazepine (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.